诺诚健华（09969）于2026年3月4日披露截至2026年2月28日的股份变动月报表。报告显示，公司法定股本与已发行股份在该月均无新增发行或回购注销活动，整体股本结构保持不变。
诺诚健华注册股本维持在25,000,000,000股普通股，面值每股0.000002美元，注册股本总额仍为50,000美元。香港联交所上市股份（股票代码：09969）本月末计1,493,798,235股已发行股份，另有2,486,000股作为库存股份，总计1,496,284,235股，与上月底持平。公司于上海证券交易所科创板上市的股份也维持在268,359,717股，未发生变动。
根据月报，公司在2026年2月并无涉及任何购回或注销行为。股权激励计划下亦无新股发行、无库藏股转让，相关限制性股票失效数量已在报告中披露，但并未因此增加已发行股份。同时，公司确认截至2026年2月末仍符合香港联交所对公众持股比例的要求。
公告由诺诚健华主席兼执行董事崔霽松博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.